Cost of war on Global Health: A short commentary

Although conflicts have existed since the beginning of human civilization, 21st century saw a surge in mass violence, wars, genocide and continued conflict. In 2008 alone, 345 conflicts were ongoing worldwide, of which 134 (39%) involved large-scale violence resulting in millions of deaths.[1]

According to the World Health Organization (WHO), war is the 19th cause of loss of disability adjusted life years, if we only take into account indirect impacts of war.

In January 2018, Turkish Medical Association, in response to the Turkish Government’s announcement of a military operation in Syria, called war a “man made public health problem”.[2] Although attaching a numerical cost to life is not this blog’s intention, rather we will try to identify the multitude of channels through which conflict and devastation affects healthcare and try to understand the short and long run costs of war on healthcare of war affected countries.

Health costs of war

Health costs of war can broadly be divided into direct and indirect costs:

Direct costs of war

The most direct consequence of war is loss of human lives. Wars affect the mental and physical health of veterans, civilians and refugees. They throw people in unsanitary conditions, preventing access to clean water, food and nutrition and increasing the risk of infectious diseases. Women are also subjected to sexual crimes during wars which leave behind deep physical and psychological scars. 

Indirect costs of war

Wounds heal. Scars stay forever

It would be a misjudgment to restrict health costs of war to the immediate death and devastation. This large-scale devastation leads to a complete breakdown of health infrastructure resulting in a public health disaster. They result in a diversion of scarce resources in the short run, reducing capacity of healthcare systems at a time when they are overburdened and needed the most.
In fact, devastating wars have been found to have a strong causal relationship with maternal deaths due to lack of access to obstetric care. Maternal deaths data between 1980 and 2008 reveal that six countries ( Pakistan, India, Nigeria, Afghanistan, Ethiopia, Democratic Republic of Congo) which were involved in armed conflict at the time of death accounted for half of maternal deaths around the world.[3]

Wars have a more lasting impact on a country through the erosion of human capital. Periods of emergency service compel young people to join the armed forces which reduces their years of education. As a consequence of this, there are fewer people in research. Although this impact cannot be felt in the short run, in the long run, continued wars harm the academic atmosphere in a country and lead to erosion of human capital.

Second generation growth models highlight how loss of human capital can consequently affect economic growth of countries, leading to further reduction in health outcomes – resulting in countries stuck in a loop with a shrinking pie. For lesser developed countries which start off with an already smaller pie and poorer attainment of education and health, a divestment from health and education can be disastrous and may throw such countries in an inescapable poverty trap. In fact, the lingering effect of war can be felt decades after the war ends.

Historical wars – Observations from three countries

Now, let us look at some countries which historically suffered the carnage of war. We will see how these countries suffered both direct and indirect costs of war, and hopefully learn some lessons from history.

Just as the Ukraine-Russia war enters its ninth week, it is imperative that we reflect on the devastating impact war has had, and continues to have, on other nations and hopefully we shall realize how human greed for power ultimately leaves all participating nations impoverished and worse off than before.

Yemen (Yemeni crisis : 2011-present)

Yemen, a low income country which was food and water insecure even before the 2000s, has been caught up in continuous wars for the last decade, perhaps witnessing the ugliest consequences of war. The United Nations has estimated around 400,000 deaths due to hunger and disease by the end of 2021- 70% of which are children. Four million people have been displaced, 14.5 million do not have enough food and 20 million out of its 30 million population require humanitarian aid. Lack of access to clean water and sanitary conditions has led to a devastating cholera outbreak.
Despite the low healthy life expectancy, there has been a steady divestment of resources for war. As a result, 7.8 million children have no access to education and very poor access to water and sanitation. The country maintains a consistently low healthcare and high military expenditure as compared to the world average[4]. In 2021, an attack on Marib, the government’s last stronghold in the north and the centre of an oil-rich province, broke out.
The UN has warned that over 100,000 people have been displaced because of the fighting there, and that two million civilians are at risk. Recently, the air war between the Houthis and the Saudi coalition has become more brutal.[5]

Vietnam (Vietnam War: 1955-1975)

The Vietnam War remains one of the darkest periods in US history. The war was marked by a large number of war crimes including massacre of civilians, bombings, rape and torture of war criminals resulting in over a million deaths. The after effects of exposure to the chemical weapon Agent Orange is still being felt today.[6] At the end of the war, Vietnam faced an inflation of 900%.[7] The US military recorded around 58,000 American casualties. The war led to widespread protests against compulsory military participation, loss of life and carnage among American citizens. Infact, the war had a heavy impact on the US veterans. An eye-opening study by Angrist empirically captures the indirect repercussions of war on labour outcomes of ex-veterans.[8] The study reveals a persistent wage differential between ex-veterans and others for years after the war.

Syria (Syrian Civil War : 2011-present)

Coming to the case of Syria- it paints a particularly alarming picture of what internal displacement as a result of war may lead to. The war has resulted in around 207,000 civilian deaths, 10% of which are children. We see a sudden spike in mortality rate of infants in 2011, the year of the commencement of the Syrian War. The alarming amount of internal displacement (fig. 1) and immigration since 2011, the beginning of the war, has led to several issues like ineffectiveness of targeted healthcare policies, advent of new diseases and congestion of healthcare systems. Refugees displaced by war in Syria are found to be at an elevated risk of contracting infectious diseases like tuberculosis, hepatitis, rabies, etc.[3]

Source: World Bank, World Development Indicators [4]

There are innumerable such instances of devastation, hunger and poverty as repercussions of war from over the world, throughout history. There can be no real winner in a war – wars mean loss of family and friends; as also poor economic growth and human development for all parties involved. However, there are wars ongoing even today in Syria, Yemen and other parts of the world, with no international consensus towards ceasefire and peace.

As we write this article, devastating wars are going on between Russia-Ukraine resulting in thousands of casualties, destruction and large-scale migration. International sanctions on Russia might lead to inflation, especially in oil prices. Both Russia and Ukraine are net wheat exporters. A breakdown in the global supply chain can lead to an increase in food prices and food insecurity. A simulation by NIESR reveals a fall in world GDP by 0.5% in 2022 and 1% by 2023 as a result of the Russia-Ukraine conflict.[9]

To what extent can we quantitatively measure the health costs of war?

Rigorously obtained scientific evidence has a huge impact in making a case and creating pressure against wars. Let us first look at some of the methodologies undertaken in previous literature. Retrospective cross-sectional surveys [9], and information surveillance systems [10] have shed light on the impact of mass violence and human rights abuses on health. Health outcomes like mortality, injuries due to violence, disability, morbidity, and mental health outcomes are commonly used health consequence indicators.

    Tools such as the Dirty War Index (DWI) that link “undesirable or prohibited” war related health outcomes like civilian dealth, torture with international humanitarian law try to quantify the effects of war.[12]

    In fact, one can use Health Adjusted Life Expectancy (HALE) that takes into account both longevity as well as quality of life. It should be noted that the impact of war is manyfold and often outside the purview of simple computation. Any measure to calculate the health costs of war should take into account both mental and physical health impacts. Measures like HALE do not take into account the deep impacts of war on mental health. No single measure can adequately take into account both the immediate and the long term costs of war. Additional costs of war also include destruction of health infrastructure and research infrastructure, brain drain due to migration, hindrance in trade of health technologies due to sanctions – to note a few. If a causal relation between all these factors and any measure of health outcome, say HALE, can be empirically established, it can be argued that such a measure is an acceptable measure of the health cost of war.

    Conclusion

    Amidst all the conflict and destruction around the world, we are reminded of the words of Albert Einstein who said, “I know not with what weapons World War III will be fought, but World War IV will be fought with sticks and stones.”  It takes years to build and seconds to destroy, and probably decades to rebuild. Through this article we tried to explore the devastating impact wars can have on human health and the many channels through which they directly or indirectly leave an adverse impact on health. We hope that we managed to convince our readers to unequivocally condemn wars, wherever they are happening and whoever is orchestrating such mass scale destruction. Militarism destroys years of toil of public health professionals and researchers and crumbles the healthcare infrastructure of countries. 

    In fact, in 2011, in a resolution passed by the World Federation of Public Health Associations it was recommended that public health professionals become active advocates for  the ratification of treaties and protocols related to war, legislation related to the arms trade and the development of initiatives that address the structural causes of war. Anti war public advocacy and activism is the need of the hour and as scholars whose work revolve around improving healthcare around the world, we cannot turn a blind eye to the current state of affairs.

    Authors: Sebanti Mukherjee and Kunal Hriday

    References

    1. Pfetsch, F. R. (2008) Conflict barometer 2008: Crises-wars-Coups d’Etat, negotiations-mediations-peace settlements. The Heidelberg Institute for International Conflict Research of Department of Political Science, University of Heidelberg, Heidelberg.
    2. Razum, O., Barros, H., Buckingham, R., Codd, M., Czabanowska, K., Künzli, N., … & Middleton, J. (2019). Is war a man-made public health problem?. The Lancet, 394(10209), 1613.
    3. Moore, S.The Impacts of War on Global Health. News Medical. https://www.news-medical.net/health/The-Impacts-of-War-on-Global-Health.aspx  
    4. World Bank, World Development Indicators.(2020). Available from https://databank.worldbank.org/source/world-development-indicators
    5. https://www.bbc.com/news/world-middle-east-29319423
    6. Sagolj, D. (2017, April 04). Vietnamese Families still battling the Aftermath of Agent Orange. Independent. https://www.independent.co.uk/life-style/health-and-families/agentorangevietnamwarusdamirsagolj-a7664491.html 
    7. Davies, N. (2015, April 22). Vietnam 40 years on: how a communist victory gave way to capitalist corruption. The Guardian. https://www.theguardian.com/news/2015/apr/22/vietnam-40-years-on-how-communist-victory-gave-way-to-capitalist-corruption 
    8. Angrist, J. D. (1990). Lifetime earnings and the Vietnam era draft lottery: evidence from social security administrative records. The American Economic Review, 313-336.
    9. Liadze, I., Macchiarelli, C., Mortimer-Lee, P., & Juanino, P. S. (2022). The Economic Costs of the Russia Ukraine Conflict. NIESR Policy Paper, 32.
    10. Coghlan, B., Brennan, R. J., Ngoy, P., Dofara, D., Otto, B., Clements, M., & Stewart, T. (2006). Mortality in the Democratic Republic of Congo: a nationwide survey. The Lancet, 367(9504), 44-51.
    11. Guha‐Sapir, D., & van Panhuis, W. G. (2004). Conflict‐related mortality: an analysis of 37 datasets. Disasters, 28(4), 418-428.
    12. Hicks, M. H. R., & Spagat, M. (2008). The Dirty War Index: A public health and human rights tool for examining and monitoring armed conflict outcomes. PLoS Medicine, 5(12), e243.

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Judit Banhazi

    Specialty
    Value and Access

    Role
    Vice President

    Degree
    MD Medicine, JD Law

    Judit Banhazi

    MD Medicine, JD Law

    Judit Banhazi, based in Basel, Switzerland, brings over 20 years of experience in HEOR, Market Access, and Health Policy.
    She has led HEOR strategies in hematology and initiated EU HTA policy activities. Judit began her career as a physician and has worked at prime global pharma companies. Her academic prowess is excellent with a peculiar combination of an MD in Medicine and a JD in Law, she has been at forefront of health economics by being involved in HTA policy discussions with EFPIA and HTAi.
    Known for her collaborative spirit and practical approach, Judit is passionate about learning and delivering quality work. Outside of work, she enjoys spending time with family and friends, travelling, and running.

    Adam Ball

    Specialty
    Business Development Manager

     

    Adam Ball

    Business Manager

    I am delighted to be part of the team here at ConnectHEOR. To tell you a bit about me, I have 10 years experience within Talent Acquisition within HEOR, RWE and Market Access. I have built a global network during this time and am excited to utilize this to help us grow as business. 

     

    Outside of work I love sports, playing football and squash regularly, as well as going to the gym. I also enjoy watching sports mainly football and tennis. I have a new born daughter too so she is taking up a lot of my time and is a bundle of joy. I also play drums and like to think I have a broad taste in Music.

     

    Eleni Tente

    Specialty
    Medical writing, Evidence planning

    Role
    Consultant, Medical writer

    Degree
    PhD – Molecular biology and genetics

    Eleni Tente

    PhD – Molecular biology and genetics

    Eleni Tente is an experienced medical writer with proven ability to translate complex scientific information into clear, concise, and impactful content to diverse audiences. She has a strong background in integrated evidence planning, publications, internal communications and e-learning development, complemented by an understanding of various therapeutic areas.

    Eleni holds a PhD in molecular biology and genetics from the University of Cambridge and an MSc in plant genetic manipulation from the University of Nottingham.

    In her free time, Eleni enjoys diving into a good book, fishing along the coast, or planning her next thrilling scuba diving adventure to swim with sharks.

    Syed Salleh

    Specialty
    HTA Modelling and Discrete-event Simulation

    Role
    Consultant, Modeling & Analytics

    Degree
    PhD – Health & Related Research

    Syed Salleh

    PhD. Health & Related Research

    Syed Salleh brings extensive experience in HTA modeling, having successfully led the development of both de novo and adaptation models for HTA listings across multiple countries, including Malaysia, Philippines, and the UK. His work spans key therapeutic franchises such as oncology, cardiometabolic, and respiratory. Syed has also delivered critical insights to healthcare professionals through MYSPOR, ITTP, and IKN virtual CME events and numerous publications.

    He holds a PhD in Health and Related Research from the School of Health and Related Research (ScHARR) at the University of Sheffield, UK, with a specialization in HTA and operational research, specifically in discrete-event simulation (DES) technique.

    During his time in a leading pharmaceutical company, Syed played a key role in securing the listing of several key products in the Malaysia Ministry of Health Formulary and served as the primary contact for DES-related projects.

    Besides work, Syed enjoys traveling, listening to music, and spending quality time with his family.

    Thai-Son Tong

    Specialty
    Model Conceptualization and Data Analytics

    Role
    Senior Consultant

    Degree
    PhD – Health Economics

    Thai-Son Tong

    PhD. Health Economics

    Thaison Tong has extensive work experience in health economics, decision modelling and big data analysis. He has a unique mix of experience in HEOR and RWE related research in academia and pharmaceutical industry. His expertise lies in health technology assessments (HTA), health economic modelling, simulation modelling, big data analytics and decision analysis. He has hands-on experience in a range of software and programming languages including R, R Shiny, R Markdown, Python, MS Excel, VBA, and Simul8. He has substantial experience of the health care system in the UK and other European countries.

    Thaison has direct experience in building cost-effectiveness models from scratch and conducting big data analysis in several disease areas including dementia, vascular disease, and cancer.

    Thaison’s PhD focus was to develop a de novo patient level model for the evaluation of different cognitive screening tests for early detection of dementia and mild cognitive impairment in primary care. He also looked at different methods for conducting economic evaluation in health care taking a broader/societal perspective. In addition, he investigated the use of Multiple Criteria Decision Analysis (MCDA) for economic evaluation.

    Thaison also holds Academic Researcher position in School of Health and Related Research (ScHARR), University of Sheffield, UK and Honorary Researcher position in University of Bristol, UK.

    Thaison’s likes to meditate, and play badminton, basketball and tennis.

    Shilpi Swami

    Specialty
    Consulting and strategy

    Role
    Vice President

    Degree
    MSc. International Economics

    Shilpi Swami

    MSc. International Economics

    Shilpi Swami is a seasoned Health Economics and Outcomes Research (HEOR) expert with experience spanning across multiple healthcare systems and therapy areas. At her current role of Vice President, HTA and Strategy, ConnectHEOR, she provides technical and strategic leadership. Additionally, Shilpi serves as the Member Engagement Co-Chair at ISPOR Oncology Special Interest Group.

    Shilpi has a comprehensive track record of leading HTA submissions and devising market access strategies on a global scale, including the EU-5, Canada, US, Latin America, Australia, and Asia. Shilpi has worked across various sectors within health economics, including academia, consulting, and biopharma. This multidimensional experience equips her with a unique ability to offer strategic insights from various stakeholders’ perspectives.

    Formerly a Research Fellow at the University of York, Shilpi has made significant contributions to public health projects and the development of best practices in the academic side of health economics. In her professional endeavors, she remains dedicated to improving healthcare through data-driven insights and evidence-based research

    Hugo Pedder

    Specialty Statistical Analysis and Evidence Synthesis

    Role Senior Consultant

    Degree PhD – Statistical Modelling

    Hugo Pedder

    PhD – Statistical Modelling

    Hugo brings in a wealth of experience to ConnectHEOR from his extensive work in academia, focusing primarily on evidence synthesis and meta-analysis. Hugo holds PhD in Statistical Modelling from University of Briston and MSc in Medical Statistics from the London School of Hygiene and Tropical Medicine, and his background in neuroscience remains a passionate interest. Alongside working with ConnectHEOR, Hugo continues to part of NICE committee. His expertise includes advanced indirect treatment comparisons technique and has extensive experience of working with the NICE in UK. 

    Beyond professional endeavors, Hugo is an enthusiastic outdoor adventurer, particularly enjoying mountain activities, climbing and ski mountaineering. From building rafts to exploring rivers in north of Sweden, he has lived an adventurous life outside of work and plans to continue to do so.

    Kunal Hriday

    Specialty
    Data science and Strategy

    Role
    Senior Consultant

    Degree
    MSc. Quantitative Economics

    Kunal Hriday

    MSc. Quantitative Economics

    Kunal Hriday is a business strategy and data science professional with experience in helping organizations crack through notorious business challenges. Kunal is proficient in business analytics, data analytics, product lifecycle management and business development. Working as a Data analytics consultant he has spent time in problem solving across variety of industries including Banking, logistics and Health and is now fully dedicated to HEOR. Kunal has hands on experience in various statistical programming tools and languages like R, Python, SAS, Excel VBA, Data Robot and data visualization tools like Power BI, Tableau and SAS VA.

    Kunal also holds a Masters in Quantitative Economics from Indian Statistical Institute and a bachelors degree in Business Economics. Excellent in business communication, he is passionate about studying environmental economics and related theories of welfare optimization.

    Raju Gautam

    Specialty
    Evidence Review

    Role
    Principal Consultant

    Degree
    PhD (Pharmacy)

    Raju Gautam

    PhD Pharmacy

    Raju Gautam spearheads evidence review at ConnectHEOR and  has extensive work experience in evidence review and synthesis, value communications, scientific publications, medical writing and project management.
    His expertise lies in systematic and targeted literature reviews, meta-analyses, network meta-analyses, value communications (AMCP and Global Value Dossiers), RWE study design and publications (manuscripts, posters, and abstracts).
    He has experience working in Global pharma companies, consulting and CRO environment for several therapy areas including Cardiovascular, Oncology, Neurology, Respiratory, Ophthalmic, Rare Diseases, and Vaccines. He has more than 40 publications in international journals as an author.
    Raju also likes jogging, yoga and meditation.

    Radha Sharma

    Specialty:
    Patient preference research, survey, In-depth interviews, COA, Evidence review and conceptualisation of study

    Role:
    Director – Patient-Centered Outcomes Research

    Degree:
    MBBS (Bachelor of Medicine and Bachelor of Surgery), PhD (Global Public Health) – University of York

    Radha Sharma

    PhD (Global Public Health)

    Radha Sharma spearheads Patient-Centered Outcomes Research at ConnectHEOR. She has a background in medicine, public health, and epidemiology.

    Her expertise includes global health research, preference elicitation, mixed-method studies, consensus workshops, qualitative health research, epidemiological analysis of big data sets, RWE study design, scientific writing, and literature reviews. Her primary focus is integrating patient perspectives into all stages of health technology assessment (HTA) and healthcare decision-making processes.

    Her extensive expertise in mixed-method studies and active patient/stakeholder engagement ensures that her research is methodologically rigorous and patient-centric. Radha is an avid hiker and enjoys exploring the beautiful Canadian Rockies.

    Kate Ren

    Specialty
    Statistical Analysis and Evidence Synthesis

    Role
    Director of Statistics

    Degree
    Ph.D Probability and Statistics

    Kate Ren

    PhD Probability and Statistics

    Kate spearheads Statistics and Evidence Synthesis at ConnectHEOR. She has more than 10 years of experience in conducting statistical analysis in HTA. Kate has PhD in Probability and Statistics specialising in Bayesian methods in clinical trial design.

    She specializes in Bayesian methods in health economics and the elicitation of experts’ beliefs and has extensive experience of conducting evidence synthesis, including, meta-analysis, network meta-analysis, MAIC, STC, ML-NMR etc. Besides working with ConnectHEOR, she is also a part of NICE Committee and University of Sheffield.

    Tushar Srivastava

    Specialty
    Decision Modelling and AI Initiatives

    Role
    Director and Principal Consultant

    Degree
    MSc – Statistics and Computing

    Tushar Srivastava

    MSc – Statistics and Computing

    Endorsed as a ‘Global Talent’ by prestigious ‘The Royal Society, UK’, Tushar is dynamic and enjoys approaching complex problems with a holistic approach. He also holds an MSc. in Statistics and has authored a handbook on higher Mathematics, “A concise handbook of vector space theory and field theory, Srivastava T.”

    In ConnectHEOR, Tushar spearhead all HEOR activities.

    Tushar’s technical expertise lies in different techniques including cost-effectiveness modelling, budget impact modelling, simulation modelling, statistical modelling and indirect comparisons analysis. He brings a unique blend of academic research, technical modelling and statistical skills and industry professionalism to support the life science industry at every stage of the product life cycle. He has a good experience in statistical analyses, including survival analysis and health related quality of life data analysis from clinical trials.

    Besides work, Tushar enjoys playing badminton, jogging, and meditating.